Editorial: Making gene therapy for osteosarcoma a reality

Full text for this resource is not available from the Research Repository.

Broadhead, Matthew L, Clark, Jonathan C. M, Choong, Peter F. M and Dass, Crispin R (2010) Editorial: Making gene therapy for osteosarcoma a reality. Expert Review of Anticancer Therapy, 10 (4). pp. 477-480. ISSN 1473-7140


Gene therapy for osteosarcoma is gaining additional momentum with the introduction of delivery vehicles such as hydrogels [52] and modified adenoviral vectors. With safer gene-delivery vehicles being produced, nucleic acid-based therapeutic constructs are becoming more amenable to clinical application. Targets such as ezrin [24], uPAR [28,29] and PEDF [30–32] have been shown to be efficacious for osteosarcoma in animal models. A combination of gene therapy and conventional therapies may yet achieve more complete disease control and warrants further evaluation for osteosarcoma.

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/7597
DOI 10.1586/era.10.18
Official URL http://dx.doi.org/10.1586/era.10.18
Subjects Historical > Faculty/School/Research Centre/Department > School of Biomedical and Health Sciences
Historical > FOR Classification > 1101 Medical Biochemistry and Metabolomics
Historical > FOR Classification > 1112 Oncology and Carcinogenesis
Historical > SEO Classification > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions)
Keywords ResPubID21867. osteosarcoma, bone cancer, gene therapy, cancer therapy, tumours, viral vector, nonviral-mediated gene therapy, animal models
Citations in Scopus 12 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login